Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bifidobacterium longum supports gut health by producing short-chain fatty acids like acetate, which inhibit pathogens and strengthen gut integrity. It also modulates immune responses through specific peptides and cell surface components that influence inflammatory pathways.
Reported Benefits (Provisional)
Origin & History
Bifidobacterium longum is a gram-positive, anaerobic probiotic bacterium naturally found in the human gastrointestinal tract. It is a ubiquitous commensal, particularly abundant in the colon. This versatile strain is widely utilized in functional foods and supplements for its established ability to support digestive health, modulate immune responses, and promote gut-brain axis balance.
Research Narrative (Provisional)
Bifidobacterium longum is one of the most extensively researched probiotic strains, with numerous in vitro, animal, and human clinical trials demonstrating its efficacy. Studies confirm its role in modulating gut microbiota, enhancing immune function, and influencing the gut-brain axis, supporting its use in various health applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Live Probiotic Cultures: Bifidobacterium longum (1-10 billion CFUs per serving) - Short-Chain Fatty Acids (SCFAs): Produced by fermentation, supporting gut barrier function and anti-inflammatory responses. - Beta-galactosidase: Enzyme facilitating lactose digestion. - Bioactive Metabolites: Modulate gut-brain axis and immune responses.
Reported Mechanism (Provisional)
Bifidobacterium longum exerts its effects primarily through the production of short-chain fatty acids (SCFAs), notably acetate, which is facilitated by ABC-type carbohydrate transporters. These SCFAs contribute to gut barrier integrity and create an unfavorable environment for pathogens. Furthermore, immunomodulatory peptides from B. longum expand IL-10 producing cells and reduce pro-inflammatory cytokines like IL-8 and IL-17A, while its CpG-rich sequences stimulate TLR9 to initiate beneficial immune signaling.
Clinical Narrative (Provisional)
Bifidobacterium longum is a highly researched probiotic strain, with extensive in vitro, animal, and human clinical trials validating its efficacy. These studies consistently demonstrate its role in modulating the gut microbiota composition, enhancing host immune function, and positively influencing the gut-brain axis. Specifically, research supports its ability to alleviate gastrointestinal discomfort and improve overall digestive health, alongside strengthening intestinal lining integrity.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.